L-Ornithine HCl.

Ornithine is what arginase leaves behind after cleaving arginine, so the pair is a direct precursor and product relationship. Each one shifts the other's pool through that single enzyme.

Arginine yields ornithine and urea in one hydrolysis, and ornithine cycles back toward arginine by way of citrulline. The loop is why the two are combined in amino formulas.

Ornithine takes on a carbamoyl group to become citrulline, the immediate step before arginine is rebuilt. The three intermediates run in fixed order.

Citrulline is formed from ornithine and regenerates ornithine each turn, making them consecutive members of the same cycle. This sequence is textbook.

Ornithine aminotransferase converts ornithine to glutamate semialdehyde and then glutamate, the direct precursor of glutamine. Ornithine therefore feeds the same nitrogen pool glutamine draws on.

Ornithine decarboxylase turns ornithine into putrescine, the first polyamine, which is built up into spermidine. Ornithine supply is the committed step of that pathway.

The arginase that produces ornithine carries manganese in its active site, so manganese status governs endogenous ornithine formation. That metal dependence is settled enzymology.

Routing ornithine toward glutamate and proline requires a pyridoxal 5-phosphate dependent aminotransferase. B6 availability decides how much ornithine takes that branch.

Two urea cycle reactions consume ATP, which functions as a magnesium complex, so magnesium status limits cycle throughput. Ornithine only moves as fast as those steps allow.

Ornithine, arginine and lysine all cross the intestinal and cell membranes on the y+ system, chiefly CAT1. A large lysine dose taken at the same time competes with ornithine for those carriers and lowers its uptake. Spacing the doses is the practical answer. The competition is a settled feature of cationic amino acid transport, not a formulation quirk.

Histidine is partly handled by the same cationic transport system that carries ornithine, so a large co-administered dose can reduce ornithine uptake. The overlap is smaller than with lysine or arginine. In a mixed free-form amino acid blend the effect on any single amino acid is modest.

Both ornithine decarboxylase, which starts polyamine synthesis, and ornithine aminotransferase, which routes ornithine toward glutamate semialdehyde, require pyridoxal-5-phosphate. Without adequate active B6 the ornithine supplied has fewer working exits from the urea cycle pool. This is settled cofactor biochemistry.

Ornithine aminotransferase converts ornithine to glutamate-5-semialdehyde, which cyclises to pyrroline-5-carboxylate and is reduced to proline. Ornithine is therefore an upstream source of proline carbon, which matters in tissues synthesising collagen. Supplying both simply covers the pathway from two points.

Arginine-glycine amidinotransferase transfers an amidino group from arginine to glycine, producing guanidinoacetate and releasing ornithine. Ornithine feeds back on that enzyme, so ornithine availability sits inside the same node as glycine and arginine. The interaction is regulatory rather than additive.

Polyamine synthesis needs both the ornithine-derived putrescine backbone and decarboxylated S-adenosylmethionine as the aminopropyl donor. Methionine supplies the SAM side of that reaction. Neither substrate alone completes the pathway, which is why the two sit together mechanistically.

Decarboxylated S-adenosylmethionine donates the aminopropyl group that converts ornithine-derived putrescine into spermidine, and again into spermine. SAM-e supplies the methionine-derived half of that chemistry. The relationship is a defined two-substrate reaction rather than a general nutrient pairing.

Zinc status has been described as influencing urea cycle enzyme activity, the pathway ornithine sits inside as the acceptor for carbamoyl phosphate. The link is reported at the level of enzyme activity and status markers rather than clinical outcomes. Read it as mechanistic support, not as a demonstrated combination effect.

Citrulline formed from ornithine condenses with aspartate to make argininosuccinate, the step that brings the second nitrogen into urea. Aspartate is therefore the obligatory partner one step downstream of ornithine in the same cycle. Supplying ornithine without aspartate availability stalls at that junction.

Ornithine and theanine are combined in products positioned around evening wind-down, on unrelated mechanisms: ornithine through nitrogen handling and theanine through glutamate and GABA receptor modulation. Any combined effect would be additive rather than mechanistically joined. This is formulation convention and the pairing has no combination trial behind it here.

GABA and ornithine appear together in evening formulas. Their mechanisms do not intersect, so the pairing is a product-design choice rather than a biochemical one. The rationale sits at the level of category convention.

The hydrochloride salt contributes chloride and a small acid load compared with the free base. In multi-gram amino acid blends that acid load is offset by alkalising mineral salts. This concerns the salt form rather than ornithine itself.

Hydrochloride amino acid salts release chloride on dissociation and add slightly to the acid load at high gram doses. Bicarbonate is the ordinary buffering counterweight in a blend. The interaction is about formulation acid-base balance, not about ornithine's own metabolism.

Carnitine and ornithine appear together in sport formulas built around exercise recovery, on distinct mechanisms: carnitine in fatty acid transfer into mitochondria and ornithine in urea cycle nitrogen handling. No combination study grounds the pairing here. Read it as product convention with separate mechanistic rationales.